Peritoneal malignant mesothelioma: Review and recent data

被引:17
作者
Mery, Eliane [1 ]
Hommell-Fontaine, Juliette [2 ]
Capovilla, Mathieu [3 ]
Chevallier, Anne [4 ]
Bibeau, Frederic [5 ]
Croce, Sabrina [6 ]
Dartigues, Peggy [7 ]
Kaci, Rachid [8 ]
Lang-Averous, Gerlinde [9 ]
Laverriere, Marie-Helene [10 ]
Leroux-Broussier, Agnes [11 ]
Poizat, Flora [13 ]
Robin, Nina [16 ]
Valmary-Degano, Severine [14 ]
Verriele-Beurrier, Veronique [15 ]
Villeneuve, Laurent [16 ]
Isaac, Sylvie [12 ]
机构
[1] Inst Claudius Regaud, Dept Anat Pathol, F-31052 Toulouse, France
[2] Hosp Civils Lyon, Ctr Hosp Lyon Sud, Serv Anat Pathol, F-69495 Pierre Benite, France
[3] Ctr Francois Baclesse, Dept Anat Pathol, F-14021 Caen, France
[4] CHU Archet II, Serv Anat Pathol, Nice, France
[5] Ctr Val dAurel, Dept Anat Pathol, Montpellier, France
[6] Insitut Bergonie, Dept Anat Pathol, Bordeaux, France
[7] Inst Gustave Roussy, Dept Anat Pathol, Villejuif, France
[8] CHU Lariboisiere, Serv Anat Pathol, Paris, France
[9] CHRU Hautepierre, Serv Anat Pathol, Strasbourg, France
[10] CHU Albert Michallon, Serv Anat Pathol, Grenoble, France
[11] Inst Cancerol Lorraine, Serv Anat Pathol, Vandoeuvre Les Nancy, France
[12] Inst J Paoli I Calmettes, Dept Pathol Anat, F-13009 Marseille, France
[13] CHU Jean Minjoz, Serv Anat Pathol, Besancon, France
[14] Ctr Paul Papin, Dept Anat Pathol, Angers, France
[15] Hosp Civils Lyon, Pole Informat Med, Unite Rech Clin, Lyon, France
[16] Ctr Jean Papin, Dept Anat Pathol, Clermont Ferrand, France
关键词
Peritoneal malignant; mesothelioma; Immunohistochemistry; Prognosis; HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; PATHOLOGICAL DIAGNOSIS; CYTOREDUCTIVE SURGERY; CONSENSUS STATEMENT; 9P21; DELETION; GUIDELINES; EXPRESSION;
D O I
10.1016/j.annpat.2014.01.004
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Peritoneal malignant mesothelioma is a rare tumor, less common than its pleural counterpart. It develops from the mesothelial cells overlying peritoneum and preferentially occurs in male, with an average age ranging from 47 to 60.5 years. Asbestos whose impact is less strong than in pleural mesothelioma, SV 40 virus, chronic peritonitis could be implicated as factors favoring the development of peritoneal mesothelioma. Clinical symptoms are not specific, and the imagery remains little or not contributive. The 2004 WHO classification recognizes 3 different types, which differ in terms of presentation and prognosis: diffuse epithelioid mesothelioma (the most common), sarcomatoid mesothelioma and biphasic mesothelioma. Many variants are described within these groups. Immunohistochemistry is mandatory to affirm or disprove peritoneal malignant mesothelioma diagnosis, based on a panel of antibodies divided in positive markers and negative markers. Indeed an accurate diagnosis is necessary to define a therapeutic strategy more and more frequently based on the combination of radical surgery and hyperthermic intra peritoneal chemotherapy. Such an approach significantly improves the prognosis of these aggressive diseases. (c) 2014 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:26 / 33
页数:8
相关论文
共 39 条
[1]   Malignant peritoneal mesothelioma in women - A study of 75 cases with emphasis on their morphologic spectrum and differential diagnosis [J].
Baker, PM ;
Clement, PB ;
Young, RH .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2005, 123 (05) :724-737
[2]   Diffuse Malignant Peritoneal Mesothelioma: Systematic Review of Clinical Management and Biological Research [J].
Baratti, Dario ;
Kusamura, Shigeki ;
Deraco, Marcello .
JOURNAL OF SURGICAL ONCOLOGY, 2011, 103 (08) :822-831
[3]   Epidemiology of peritoneal mesothelioma: a review [J].
Boffetta, P. .
ANNALS OF ONCOLOGY, 2007, 18 (06) :985-990
[4]  
Bridda Alessio, 2007, MedGenMed, V9, P32
[5]  
Cerruto CA, 2006, ARCH PATHOL LAB MED, V130, P1654
[6]   DIFFUSE MALIGNANT MESOTHELIOMA - PROSPECTIVE EVALUATION OF 69 PATIENTS [J].
CHAHINIAN, AP ;
PAJAK, TF ;
HOLLAND, JF ;
NORTON, L ;
AMBINDER, RM ;
MANDEL, EM .
ANNALS OF INTERNAL MEDICINE, 1982, 96 (06) :746-755
[7]   Impact of Tumor Angiogenesis in Peritoneal Mesothelioma After Radical Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy [J].
Chua, Terence C. ;
Yao, Peng ;
Akther, Javed ;
Morris, David L. .
PATHOLOGY & ONCOLOGY RESEARCH, 2010, 16 (02) :217-222
[8]   Outcomes of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Mesothelioma: The Australian Experience [J].
Chua, Terence C. ;
Yan, Tristan D. ;
Morris, David L. .
JOURNAL OF SURGICAL ONCOLOGY, 2009, 99 (02) :109-113
[9]  
Churg A., 2006, Tumors of the serosal membranes
[10]   Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy [J].
Feldman, AL ;
Libutti, SK ;
Pingpank, JF ;
Bartlett, DL ;
Beresnev, TH ;
Mavroukakis, SM ;
Steinberg, SM ;
Liewehr, DJ ;
Kleiner, DE ;
Alexander, HR .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (24) :4560-4567